EUVIMEDOdkrijte EUVIMED
CrossrefInformačná karta

Coexisting growing teratoma syndrome and gliomatosis peritonei following ovarian immature teratoma: a case report and literature review

OSMAN TÜRKMEN, SERRA AKAR İNAN, SERAP AKBAY, MOHAMMAD İBRAHİM HALİLZADE, İNCİ HALİLZADE, ÖZLEM MORALOĞLU TEKİN

Turkish Journal of Medical Sciences · 2024-12-10 · 54 (6) · 1192-1197

DOI: 10.55730/1300-0144.5899 ↗
AbstraktBibliografické údaje

Abstrakt

Background/aim: Growing teratoma syndrome (GTS) is marked by the reduction in serum tumor markers, despite the growth of a benign mature teratomatous mass after chemotherapy treatment for germ cell tumors. Gliomatosis Peritonei (GP) is often seen with ovarian teratomas, involving the spread of mature glial tissue on the peritoneum. The coexistence of GP with GTS following treatment for ovarian immature teratoma (IMT) is particularly rare with about 20 cases reported thus far.Case: A 25-year-old patient underwent surgical removal of an adnexal mass. On paraffin pathology, she was deemed to have stage III A grade 3 ovarian IMT with parametrial involvement. After receiving 2 cycles of BEP chemotherapy, imaging showed the appearance of new lesions adjacent to the liver and on the pelvic peritoneum. She underwent a second fertility sparing surgery and paraffin examination revealed mature teratoma within the removed specimen. The resected pelvic peritoneum revealed mature glial tissue nodules consistent with GP.Conclusion: The coexistence of GP with GTS after ovarian IMT surgery poses a diagnostic challenge in the differentiation between malignant and benign components, which is crucial for avoiding unnecessary aggressive treatments. The recognition of such cases may enable the employment of fertility sparing surgery in the treatment of these patients.

Vedomosti, ktoré zodpovedajú vašej práci.

Od bezplatného začiatku cez osobnú rešerš literatúry až po kompletný Research Suite.

Zobraziť tarify →

Sú zahrnuté všetky plné texty vydavateľov?

Nie. Bibliografické záznamy, abstrakty a plné texty sú odlišné typy obsahu. To, či je plný text dostupný, závisí od zdroja, Open Access a vašich existujúcich licencií. Tarif EUVIMED nenahrádza dodatočné práva vydavateľa.

Zobraziť tarify →